These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2197076)

  • 21. d-Fenfluramine selectively suppresses carbohydrate snacking by obese subjects.
    Wurtman J; Wurtman R; Mark S; Tsay R; Gilbert W; Growdon J
    Int J Eat Disord; 1985; 4(1):89-99. PubMed ID: 11540865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effect of dexfenfluramine on amino acid profiles and food selection in obese patients during weight loss.
    Breum L; Møller SE; Andersen T; Astrup A
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):147-53. PubMed ID: 8646251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The involvement of brain serotonin in excessive carbohydrate snacking by obese carbohydrate cravers.
    Wurtman JJ
    J Am Diet Assoc; 1984 Sep; 84(9):1004-7. PubMed ID: 6381575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the mechanism of action of dexfenfluramine: effect on alliesthesia and appetite motivation in lean and obese subjects.
    Blundell JE; Hill AJ
    Clin Neuropharmacol; 1988; 11 Suppl 1():S121-34. PubMed ID: 3180107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. A double-blind placebo-controlled study.
    Lafreniere F; Lambert J; Rasio E; Serri O
    Int J Obes Relat Metab Disord; 1993 Jan; 17(1):25-30. PubMed ID: 8383638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [International study of the effect of dexfenfluramine in obesity (ISIS): 6 months' results].
    Guy-Grand B; Apfelbaum M; Crepaldi G; Gries A; Lefebvre P; Turner P
    Rev Med Interne; 1989; 10(3):271-7. PubMed ID: 2669089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine and metabolic effects of dexfenfluramine in patients with android obesity.
    Ditschuneit HH; Flechtner-Mors M; Dolderer M; Fulda U; Ditschuneit H
    Horm Metab Res; 1993 Nov; 25(11):573-8. PubMed ID: 8288160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Control of appetite with dexfenfluramine in treatment of obesity].
    Blundell JE; Hill AJ
    Pol Tyg Lek; 1995; Suppl 1():11-9. PubMed ID: 7596899
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical studies with d-fenfluramine.
    Guy-Grand B
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):173S-176S. PubMed ID: 1728829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Energy expenditure and substrate oxidation rates of obese rats during a 12-day treatment with dexfenfluramine.
    Boschmann M; Aust L; Frenz U; Noack R
    Ann Nutr Metab; 1996; 40(1):10-23. PubMed ID: 8722302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chronic administration of dexfenfluramine on stress- and palatability-induced food intake in rats.
    Souquet AM; Rowland NE
    Physiol Behav; 1989 Aug; 46(2):145-9. PubMed ID: 2602451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexfenfluramine and appetite in humans.
    Blundell JE; Hill AJ
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S51-9. PubMed ID: 1338323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemodynamic, metabolic and endocrine effects of short-term dexfenfluramine treatment in young, obese women.
    Andersson B; Zimmermann ME; Hedner T; Björntorp P
    Eur J Clin Pharmacol; 1991; 40(3):249-54. PubMed ID: 2060560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of dexfenfluramine in a weight loss program for obese infertile women.
    Galletly C; Clark A; Tomlinson L
    Int J Eat Disord; 1996 Mar; 19(2):209-12. PubMed ID: 8932560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin and dietary fat intake: effects of dexfenfluramine.
    Blundell JE; Lawton CL
    Metabolism; 1995 Feb; 44(2 Suppl 2):33-7. PubMed ID: 7869935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A placebo-controlled trial of d-fenfluramine in bulimia nervosa.
    Fahy TA; Eisler I; Russell GF
    Br J Psychiatry; 1993 May; 162():597-603. PubMed ID: 8149110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic abnormalities linked to obesity: effects of dexfenfluramine in the corpulent rat.
    Brindley DN; Russell JC
    Metabolism; 1995 Feb; 44(2 Suppl 2):23-7. PubMed ID: 7869933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tolerance and acceptability of dexfenfluramine in the long-term treatment of obesity in private practice. ESIM Group].
    Héraïef E
    Rev Med Suisse Romande; 1997 Jan; 117(1):19-24. PubMed ID: 9082531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical studies with dexfenfluramine: from past to future.
    Guy-Grand B
    Obes Res; 1995 Nov; 3 Suppl 4():491S-496S. PubMed ID: 8697048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International trial of long-term dexfenfluramine in obesity.
    Guy-Grand B; Apfelbaum M; Crepaldi G; Gries A; Lefebvre P; Turner P
    Lancet; 1989 Nov; 2(8672):1142-5. PubMed ID: 2572857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.